| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine, Divisions of Endocrinology and Metabolism and Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Address requests for reprints to:Aaron I.Vinik, MD., University of Michigan Medical Center, 2922B Taubman Health Care Center, Ann Arbor, Michigan 48109.
To determine if cardiac autonomic neuropathy CAN) contributes to diabetic cardiomyopathy, left ventricular function was assessed by resting and exercise radionuclide ventriculography (RVG) in 30 patients with long-standing insulindependent diabetes mellitus who had no clinical, electrocardiographic, or tomographic thallium scan evidence of heart disease. In 11 of 30 patients (37%), RVG revealed abnormal left ventricularperformance* CAN was found in 91% of these patients. RVG was abnormal in 59% of patients with CAN and in only 8% of patients without CAN (P <0.005). There were significant reductions in mean (±SE) ejection fractions (EF) in patients with CAN at rest (62.8 ± 2.2% vs. 75.2 ± 2.5%; P <0.001) and with maximal exercise (65.8 ± 2.6% vs. 80.9 ± 2.3%; P <0.001) compared to patients without CAN. There was an inverse correlation between the autonomic function score and both resting EF (r = -0.53; P <0.002) and exercise EF (r = -0.55; P <0.002). Systolic function did not correlate with age, sex, duration or control of diabetes, microvascular complications, or plasma norepinephrine levels.
Thus, approximately one third of our study population had evidence for depressed left ventricular function in the absence of ischemic heart disease, and the cardiac dysfunction was related to the severity of CAN. CAN may be a contributor to cardiac dysfunction in diabetes mellitus.
* This work was supprted by grants to the Clinical Research Center (5M01-RR-00042-22)and the Michigan Diabetes Research and Training Center (AM-20572-07).
Received December 20, 1985.
This article has been cited by other articles:
![]() |
A. Stefanidis, S. Bousboulas, J. Kalafatis, K. Baroutsi, P. Margos, K. Komninos, S. Pappas, and E. Papasteriadis Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults Eur J Echocardiogr, July 1, 2009; 10(5): 647 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kusmic, S. Morbelli, C. Marini, M. Matteucci, C. Cappellini, E. Pomposelli, P. Marzullo, A. L'Abbate, and G. Sambuceti Whole-Body Evaluation of MIBG Tissue Extraction in a Mouse Model of Long-Lasting Type II Diabetes and Its Relationship with Norepinephrine Transport Protein Concentration J. Nucl. Med., October 1, 2008; 49(10): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726. [Full Text] [PDF] |
||||
![]() |
A. A Little, J. L Edwards, and E. L Feldman Diabetic neuropathies Practical Neurology, April 1, 2007; 7(2): 82 - 92. [Full Text] [PDF] |
||||
![]() |
C. Patel, K. L Wyne, and D. K McGuire Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diabetes and Vascular Disease Research, May 1, 2005; 2(2): 61 - 66. [Abstract] [PDF] |
||||
![]() |
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Scott and P. L. Kench Cardiac Autonomic Neuropathy in the Diabetic Patient: Does 123I-MIBG Imaging Have a Role to Play in Early Diagnosis? J. Nucl. Med. Technol., June 1, 2004; 32(2): 66 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration Diabetes Care, February 1, 2004; 27(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I M Al-Shafei, R G Wise, G A Gresham, T A Carpenter, L D Hall, and C. L-H Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 15, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) J. Am. Coll. Cardiol., September 1, 2000; 36(3): 970 - 1062. [Full Text] [PDF] |
||||
![]() |
Z. Pietrzyk, S. Vogel, G. J. Dietze, and S. F. Rabito Augmented Sympathetic Response to Bradykinin in the Diabetic Heart Before Autonomic Denervation Hypertension, August 1, 2000; 36(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Stevens, D. M. Raffel, K. C. Allman, F. Dayanikli, E. Ficaro, T. Sandford, D. M. Wieland, M. A. Pfeifer, and M. Schwaiger Cardiac Sympathetic Dysinnervation in Diabetes : Implications for Enhanced Cardiovascular Risk Circulation, September 8, 1998; 98(10): 961 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bernbaum, S. G. Albert, and J. D. McGarry Diabetic Neuropathy and Braille Ability Arch Neurol, November 1, 1989; 46(11): 1179 - 1181. [Abstract] [PDF] |
||||
![]() |
Y. HARATI Diabetic Peripheral Neuropathies Ann Intern Med, October 1, 1987; 107(4): 546 - 559. [Abstract] [PDF] |
||||
![]() |
A. I M Al-Shafei, R G Wise, G A Gresham, T A Carpenter, L D Hall, and C. L-H Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 15, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |